Kg-1-Luc-mCh-Puro: Human Leukemia (AML)


(actual study data; representative)

Parameter Information
Strain NSG
Implant Type Cells
Implant Location IV
Time to Staging 7 days
Time to Evaluation Size 35.9 days
Td 3.0 days

(The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact Covance.)

Histotype: Leukemia [AML]

Tumor Line: Human

REF# 2878